The Supreme Court has ordered the government to establish a committee to investigate unethical pharmaceutical marketing. The committee is to evaluate current regulatory frameworks and enforcement mechanisms. It must also consult stakeholders and submit recommendations within two months of its first meeting. After reviewing the committee's report, the government will prepare a compliance affidavit. The court is set to consider this affidavit in a hearing scheduled for January 29.